scispace - formally typeset
H

Hui-Ling Yen

Researcher at Li Ka Shing Faculty of Medicine, University of Hong Kong

Publications -  122
Citations -  16374

Hui-Ling Yen is an academic researcher from Li Ka Shing Faculty of Medicine, University of Hong Kong. The author has contributed to research in topics: Virus & Influenza A virus subtype H5N1. The author has an hindex of 43, co-authored 110 publications receiving 12666 citations. Previous affiliations of Hui-Ling Yen include University of Michigan & St. Jude Children's Research Hospital.

Papers
More filters
Journal ArticleDOI

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.

TL;DR: Results of an analysis of nasal and throat swabs from 17 patients in Zhuhai, China, who had received a diagnosis of Covid-19 and found SARS-CoV-2 Viral Load in Upper Respiratory Specimens positive.
Journal ArticleDOI

Respiratory virus shedding in exhaled breath and efficacy of face masks.

TL;DR: A study of 246 individuals with seasonal respiratory virus infections randomized to wear or not wear a surgical face mask showed that masks can significantly reduce detection of coronavirus and influenza virus in exhaled breath and may help interrupt virus transmission.
Journal ArticleDOI

Stability of SARS-CoV-2 in different environmental conditions.

TL;DR: This preprint is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Journal ArticleDOI

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters.

TL;DR: The pathogenicity and transmissibility of SARS-CoV-2 in golden (Syrian) hamsters resemble features of COVID-19 in human patients, suggesting that these hamsters could be used to model this disease.
Journal ArticleDOI

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.

TL;DR: In vitro antiviral effect of compounds that were previously reported to inhibit coronavirus replication and compounds that are currently under evaluation in clinical trials for SARS-CoV-2 patients are evaluated.